---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-24-000073"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:55:54.620424+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Praxis Precision Medicines shareholders approve 870K share increase for 2020 equity plan

## Summary
- Stockholders elected Dean Mitchell and Jill DeSimone as Class I directors for terms ending 2027.
- Ratified Ernst & Young as independent auditor for FY 2024 with 15.3M votes for.
- Approved amendment to 2020 Stock Plan, increasing authorized shares by 870,000 (9.1M for, 5.1M against).
- Advisory vote on executive compensation passed with 10.0M for, 4.1M against.

## SEC filing metadata
- accession: 0001689548-24-000073
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/0001689548-24-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/prax-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-24-000073
- JSON: https://secwatch.observer/filing/0001689548-24-000073.json
- Plain text: https://secwatch.observer/filing/0001689548-24-000073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.